Hypertension after renal transplantation

Area of Science:

• Nephrology
• Cardiology
• Transplantation Medicine

Background:

• Arterial hypertension is a frequent complication in renal transplant recipients.
• Cyclosporine immunosuppression is standard, but its long-term effects on blood pressure require investigation.
• Graft function and patient survival are significantly impacted by post-transplant hypertension.

Purpose of the Study:

• To determine the prevalence and risk factors of arterial hypertension in renal transplant recipients.
• To assess the impact of hypertension control on graft outcomes.
• To evaluate the potential protective effect of nifedipine on renal transplant recipients.

Main Methods:

• Prospective study of 212 renal transplant recipients with 5-year follow-up.
• Logistic regression analysis to identify hypertension risk factors.
• Comparison of graft failure rates and plasma creatinine levels between controlled and uncontrolled hypertensive patients and normotensive controls.
• Evaluation of nifedipine's effect by comparing outcomes in patients receiving it versus those not on calcium channel blockers.

Main Results:

• Hypertension prevalence was high (81.6% at 1 year, 81.2% at 5 years).
• Pre-transplant hypertension, elevated creatinine (>2 mg/dL) at 1 year, and corticosteroid therapy were associated with post-transplant hypertension.
• Uncontrolled hypertension led to significantly higher graft failure rates and worse renal function.
• Nifedipine use did not show significant differences in acute tubular necrosis, rejection rates, or renal function compared to non-calcium channel blocker users.

Conclusions:

• Arterial hypertension is highly prevalent and a significant risk factor for poor graft outcomes in renal transplant recipients.
• Early identification and management of hypertension risk factors are crucial.
• Nifedipine did not demonstrate a significant protective role in this cohort.